03:01 PM EST, 11/17/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) owner, Novo Holdings, is set to sell its 7.8% stake in UK-based medical products company ConvaTec Group, multiple news outlets reported Monday.

The company is offering about 155 million shares in an overnight placing with investors, with the deal expected to price at 2.27 British pounds ($2.99) per share, according to Bloomberg.

The sale marks the foundation's full exit from ConvaTec, with Novo Holdings having monetized all previously held shares through derivatives transactions, which are expected to settle alongside the current offering, the news outlet added.

Novo Holdings did not immediately respond to MT Newswires' request for comment.

Price: 48.56, Change: +0.30, Percent Change: +0.62